SEC Form 4 · accession 0000899243-17-004099
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas O Daniel
Director
Period of report
Feb 13, 2017
Accepted (ET)
Feb 14, 2017 · 8:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2017 | A | 10,765 | $4.18 | A | 10,765 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2017 on quarterly basis in arrears.